LexDanaLexDanabeta
Inventor

AIJUN LU

Inventor
CN

Overview

3→
Patents
2023–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
PatentTitleYear
12,559,4711,5-dihydro-2,4-benzodiazepine-3-one derivative and application thereof202612,187,742Dual ATM and DNA-PK inhibitors for use in anti-tumor therapy202511,760,744Fused ring compounds2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023Patents assigned to GENENTECH INC (1)· patent assignee history
2023–2026Based in CN· patent location history
2025Patents assigned to XRAD THERAPEUTICS INC (1)· patent assignee history
2026Patents assigned to JIANGSU NHWA PHARMACEUTICAL CO LTD (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GENENTECH INC12023
JIANGSU NHWA PHARMACEUTICAL CO LTD12026
XRAD THERAPEUTICS INC12025
Locations
LocationPatentsSpan
CN32023–2026